CLEC4E (Mincle): Macrophage-Inducible C-Type Lectin Receptor in Innate Immunity and Disease

A comprehensive biomedical overview of CLEC4E, encoding the Mincle receptor, covering genomic architecture, expression patterns, disease associations, and functional implications.

Gene Information Card

Symbol CLEC4E
Full Name C-type lectin domain family 4 member E
Gene Type protein-coding
Chromosomal Location 12p13.2
NCBI Gene ID 26253 ncbi.nlm.nih.gov/gene/26253
Ensembl ID ENSG00000166523
UniProt ID Q9ULY5
OMIM ID 612922
HGNC ID 14555
Aliases Mincle, CLECSF9, Clecsf9

Description

CLEC4E (C-type lectin domain family 4 member E), commonly known as Mincle (macrophage-inducible C-type lectin), is a type II transmembrane protein primarily expressed on myeloid cells. It functions as a pattern recognition receptor (PRR) that recognizes specific carbohydrate ligands, including mycobacterial trehalose dimycolate (TDM, cord factor) and certain fungal components. Upon ligand binding, CLEC4E signals through the Fc receptor gamma-chain (FcRγ) to activate NF-κB and MAPK pathways, promoting pro-inflammatory cytokine production and innate immune responses. It is involved in the host defense against pathogens, particularly Mycobacterium tuberculosis, and has been implicated in sterile inflammation and autoimmune conditions.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Tuberculosis CLEC4E recognizes mycobacterial trehalose dimycolate (TDM), activating macrophages and dendritic cells via FcRγ-Syk-CARD9 signaling, leading to pro-inflammatory cytokine production and granuloma formation. Strong evidence from in vitro and in vivo studies; CLEC4E-deficient mice show impaired control of M. tuberculosis infection.
Fungal Infections CLEC4E binds to α-mannose residues on fungal pathogens like Candida albicans and Malassezia species, triggering innate immune responses. Experimental evidence in mouse models and human cell lines.
Autoimmune Diseases (e.g., Rheumatoid Arthritis) CLEC4E can recognize endogenous ligands such as SAP130 released from necrotic cells, contributing to sterile inflammation and potentially exacerbating autoimmune responses. Evidence from animal models and expression studies in human synovial tissue.
Ischemia-Reperfusion Injury CLEC4E senses damage-associated molecular patterns (DAMPs) like SAP130 from dying cells, promoting inflammatory responses in ischemic tissues. Preclinical studies in mouse models of myocardial infarction and stroke.

Expression Profile

Tissue Expression
Tissue nTPM level
Lung 8.5 Low
Spleen 7.2 Low
Bone Marrow 6.1 Low
Whole Blood 5.4 Low
Liver 3.8 Not detected
Brain 1.2 Not detected
Cell Line Expression
Cell Line nTPM Notes
THP-1 (Monocyte) 12.3 High expression; inducible by PMA differentiation.
U937 (Monocyte) 9.8 Moderate expression; upregulated upon stimulation.
HL-60 (Promyeloblast) 6.5 Low basal expression; inducible.
K-562 (Lymphoblast) 2.1 Very low expression.
A549 (Lung Carcinoma) 1.5 Minimal expression.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
rs10841845 (G>A) SNP (Intronic) Minor allele frequency ~0.25 Associated with altered CLEC4E expression levels in some studies; potential link to tuberculosis susceptibility.
rs7950894 (C>T) SNP (Intronic) Minor allele frequency ~0.15 No significant functional effect reported; may influence regulatory elements.
rs10841847 (T>C) SNP (Intronic) Minor allele frequency ~0.10 No known clinical significance.
Mutation functional classification

Loss of Function (LOF)

Complete loss-of-function mutations in CLEC4E are rare. However, studies using CLEC4E knockout mice demonstrate impaired recognition of TDM and reduced pro-inflammatory cytokine production, leading to increased susceptibility to mycobacterial infections.

Gain of Function (GOF)

No naturally occurring gain-of-function mutations have been documented. Overexpression of CLEC4E in vitro enhances inflammatory responses to its ligands.

Dominant Negative (DN)

No dominant-negative mutations have been reported for CLEC4E.

Gene Ontology (GO)

• carbohydrate binding • metal ion binding
• membrane • integral component of membrane
• innate immune response • signal transduction
• cell surface receptor signaling pathway • inflammatory response
• positive regulation of cytokine production • response to lipopolysaccharide

Pathways

• Fc gamma receptor (FcγR)-mediated signaling
• Syk (Spleen Tyrosine Kinase) signaling
• CARD9 (Caspase recruitment domain-containing protein 9) signaling
• NF-kappa B signaling
• MAPK signaling

Protein Summary

The CLEC4E protein, Mincle, is a 219-amino acid type II transmembrane receptor with a single extracellular C-type lectin-like domain (CTLD). It forms a homodimer and associates with the immunoreceptor tyrosine-based activation motif (ITAM)-containing adaptor protein FcRγ. Ligand binding induces phosphorylation of the ITAM, recruiting Syk kinase, which activates downstream signaling cascades including CARD9, NF-κB, and MAPKs. This leads to the production of pro-inflammatory cytokines (e.g., TNF-α, IL-6, IL-12) and chemokines, orchestrating innate immune responses. Mincle is crucial for recognizing mycobacterial cord factor and certain fungal species, and also senses damage-associated molecular patterns (DAMPs) from necrotic cells, linking it to sterile inflammation.

Related Products

Product name Cat.No. Species Gene ID
CLEC4E Knockout HEK293 Cell Line EDJ-KQ8485 Human 26253 Details Get a Quote
CLEC4E Knockout HeLa Cell Line EDJ-KQ55910 Human 26253 Details Get a Quote
CLEC4E Knockout A-549 Cell Line EDJ-KQ64400 Human 26253 Details Get a Quote
CLEC4E Knockout HCT 116 Cell Line EDJ-KQ72852 Human 26253 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: